More weight lost on GLP-1s actually lowers complication risk, ECO data says
Posted by tiredmira in Weight Loss & Metabolic - 2 points, 0 comments.
There's a new ECO 2026 presentation showing that the more weight people lose on GLP-1 meds, the lower their risk of obesity-related complications. Basically a dose-response relationship, which honestly is what you'd hope for but it's good to see it laid out with bigger numbers.
What caught my eye is they're framing it as a continuous thing, not just "did you hit 5% or 10%." For me that tracks, because the appetite suppression and the actual health markers like fasting glucose and blood pressure felt like they kept improving the longer I titrated up, not just at some magic threshold.
I'm a bit skeptical though, since this is an abstract presentation and not a peer-reviewed paper yet. Anyone know if they're stratifying by which GLP-1, or pooling everything together? That matters a lot when comparing tirz vs sema vs the newer ones.
Community discussion - research and educational context only. Not medical advice.